Triage Survey for Neurology Research Eligibility (TRIAGE-Neuro)

Adams Clinical

Status: Enrolling

Conditions: Alzheimer Disease

Treatments: Other: Survey; Other: Optional Medication Washout

Study type: Observational

Funder types: NETWORK

Identifiers

NCT06104852

TRIAGE-Neuro-101

Details and patient eligibility

About

TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials.

Full description

TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials. Secondary objectives include identifying participant characteristics among the clinical trial-seeking population, identifying the percentage of potential participants currently taking prescribed memory medications that could exclude them from clinical trial participation, examining how changes in prescription memory medications impact performance on cognitive assessments, and identifying the percentage of potential participants whose laboratory results could exclude them from clinical trial participation.

Enrollment: 600 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Participant and study partner (when applicable) have signed an ICF prior to study-specific procedures being performed.
• Participant and study partner (when applicable) are at least 18 years old.

Exclusion criteria

• Participant lacks the language skills or cognitive ability to understand the screening process.
• Participant is pregnant, breast-feeding, or planning to become pregnant.
• History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
• Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on Columbia-Suicide Severity Rating Scale questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
• Moderate or severe substance use disorder within 90 days prior to screening, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
• Any condition that in the investigator's opinion makes a participant unsuitable for the study.
• Currently employed by Adams Clinical or a first-degree relative of an employee working on this study.